Technical Analysis for TVTX - Travere Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 9.17% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 9.17% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 9.17% | |
Bollinger Band Squeeze | Range Contraction | 9.17% | |
NR7 | Range Contraction | 9.17% | |
Fell Below 20 DMA | Bearish | 11.45% | |
Bollinger Band Squeeze | Range Contraction | 11.45% | |
Earnings Movers | Other | 11.45% | |
BB Squeeze + Upper Band Touch | Range Contraction | 11.45% | |
Outside Day | Range Expansion | 11.45% |
Alert | Time |
---|---|
Possible Pocket Pivot | 22 minutes ago |
New 52 Week High | about 1 hour ago |
Up 10% | about 1 hour ago |
Up 1 ATR | about 4 hours ago |
60 Minute Opening Range Breakout | about 4 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical IBD 50 Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical IBD 50 Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.25 |
52 Week Low | 5.12 |
Average Volume | 2,082,683 |
200-Day Moving Average | 9.68 |
50-Day Moving Average | 15.21 |
20-Day Moving Average | 17.76 |
10-Day Moving Average | 17.74 |
Average True Range | 1.09 |
RSI (14) | 57.45 |
ADX | 42.51 |
+DI | 21.26 |
-DI | 12.05 |
Chandelier Exit (Long, 3 ATRs) | 15.99 |
Chandelier Exit (Short, 3 ATRs) | 18.76 |
Upper Bollinger Bands | 18.59 |
Lower Bollinger Band | 16.93 |
Percent B (%b) | 0.44 |
BandWidth | 9.35 |
MACD Line | 0.69 |
MACD Signal Line | 0.93 |
MACD Histogram | -0.238 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 18.79 | ||||
Resistance 3 (R3) | 18.75 | 18.33 | 18.60 | ||
Resistance 2 (R2) | 18.33 | 18.05 | 18.35 | 18.53 | |
Resistance 1 (R1) | 18.00 | 17.87 | 18.17 | 18.04 | 18.47 |
Pivot Point | 17.58 | 17.58 | 17.67 | 17.60 | 17.58 |
Support 1 (S1) | 17.25 | 17.30 | 17.42 | 17.29 | 16.85 |
Support 2 (S2) | 16.83 | 17.12 | 16.85 | 16.79 | |
Support 3 (S3) | 16.50 | 16.83 | 16.72 | ||
Support 4 (S4) | 16.54 |